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Background: Global longitudinal strain (GLS) based on two-dimensional speckle-
tracking echocardiography (2D-STE) might better reflect left ventricular (LV) 
contractile performance than conventional parameters. Recently, left atrial (LA) strain 
has been used as a more accurate alternative to assessing LA performance. The aim in 
this study was to assess the clinical prognostic value of left ventricular GLS (LV GLS) 
and peak atrial longitudinal strain (PALS) in patients after ST-segment-elevation 
myocardial infarction (STEMI). 
Methods: The study enrolled 199 patients who underwent primary percutaneous 
coronary intervention (pPCI) for first STEMI. Conventional and 2D-STE were 
performed within 48 h after pPCI. LV GLS and PALS were related to LV remodeling 
at 6-month follow-up and to adverse events.  
Results: Diabetes mellitus, GLS and PALS independently predicted LV remodeling. 
With multivariable Cox proportional hazards, diabetes mellitus, GLS and PALS were 
predictive of adverse clinical outcomes. However, PALS did not add significant 
incremental value beyond LV GLS in the prediction of LV remodeling (increase in 
area under the receiver-operator characteristic curve [AUC]: 0.05, p = 0.24) and 
clinical events (even a decrease in AUC: 0.03, p = 0.69).  
Conclusions: Both GLS and PALS provide independent prognostic value for adverse 
LV remodeling and clinical outcomes after STEMI. However, the ability of the 
combination of PALS and GLS to predict LV remodeling and clinical outcomes may 
not be superior to that of a single indicator.  
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It is well known that outcomes of ST-segment-elevation myocardial infarction 
(STEMI) have dramatically improved in recent years because of the introduction of 
modern thrombolytic drugs and percutaneous coronary intervention (PCI). However, 
left ventricular (LV) remodeling still occurs in 30–35% of patients [1, 2]. There is a 
progressive change in myocardial wall and ventricular structure, including expansion 
in the infarct region, wall thinning, and ventricular dilation in the non-infarcted region 
[3], which may be followed by adverse cardiovascular events and an increase 
mortality rate [4]. The introduction of two-dimensional speckle-tracking 
echocardiography (2D-STE) may contribute to quantification of LV global and 
regional systolic function [5]. Previous studies have shown that global longitudinal 
strain (GLS) can be used to predict LV remodeling and cardiovascular events after 
STEMI [6–9]. However, some studies showed that like GLS, global circumferential 
strain (GCS) and circumferential strain rate are independent predictors of LV 
remodeling [10]. 
Left atrial volumes and LA function have been recognized as significant 
predictors of adverse events in a range of cardiovascular diseases [11, 12]. Recently, 
2D-STE is shown to be feasible for measuring LA deformations, thus allowing 
analysis of LA reservoir function (peak atrial longitudinal strain [PALS]) during the 
LV systolic phase [13]. More recently, LA reservoir function measured by PALS has 
shown good predictive value, even independently of LV GLS and LA volume [14, 
15]. However, the additional value of PALS in patients with decreased LV GLS is 
questionable. A previous study proved that the prognostic value of PALS in patients 
with acute myocardial infarction is dependent on LV GLS and LA size [16].  
Accordingly, the purpose of this study was to explore in patients with STEMI in: 
the clinical and prognostic importance of both LV GLS and PALS on LV remodeling 
and clinical outcome and prognostic information incremental of PALS to clinical data 




In this prospective study, a total of 216 patients diagnosed with STEMI treated 
with primary PCI (pPCI)were enrolled from September 2017 to March 2018. The 
inclusion criteria were as follows: age 18 to 80 years, STEMI with onset of pain < 12 
hours before pPCI, and admission with STEMI based on present guidelines [17]. The 
exclusion criteria were: previous myocardial infarction or coronary artery bypass, 
significant valvular dysfunction, ventricular arrhythmia, atrial fibrillation or paced 
rhythm, and noncardiac disease with a life expectancy of < 1 year. 
All patients were treated according to present cardiology guidelines. Before pPCI, 
they were given a loading dose of acetylsalicylic acid (ASA), 600 mg of clopidogrel, 
and 100 IU/kg of heparin (maximum 5,000 IU). This prospective study was approved 
by the Ethics Committee of the First Hospital of Lanzhou University. All patients 
signed informed consent forms. 
 
Echocardiography 
Echocardiographic data were obtained using the EPIQ 7C (Kininklijke Philips 
NV, Eindhoven, The Netherlands). Echocardiographic images were obtained by 
recording 3 consecutive heart cycles during apnea according to the guidelines of the 
American Society of Echocardiography [5]. Two experienced observers performed all 
patient views offline using an echocardiographic analysis system (QLAB Advanced 
Tissue Motion Quantification, Phillips). 
Left ventricular end-systolic volume (LVESV), LV end-diastolic volume 
(LVEDV) and LV ejection fraction (LVEF) were determined using the biplane 
Simpson method in 4-, 3-, and 2-chamber views. The LV was divided into 16 
segments, and segments were graded (1 = normokinetic, 2 = hypokinetic, 3 = akinetic, 
4 = dyskinetic) according to subjective assessments of wall motion amplitude and 
changes in LV thickness at systole. The wall motion score index (WMSI) was defined 
as the sum of the segment score ratings divided by the number of segments scored. 
Pulsed-wave Doppler variables were measured by placing at the tip of the mitral valve 
(MV) leaflets from the apical four-chamber view during diastole. The peak velocity of 
early (E) and late (A) diastole and the MV deceleration time were measured, and the 
E/A ratio was calculated. The measurements of myocardial peak early velocity (e’) 
were performed at the lateral and medial mitral annulus. E/e’ were obtained by 
dividing E by e’. 
 
LV strain analysis 
Two-dimensional echocardiographic images were obtained from 4-, 3-, and 2-
chamber and midventricular short-axis views with frame rates of 60 to 90 frame/s. 
2D-STE was performed using the commercially available software QLAB Advanced 
Tissue Motion Quantification (Philips) equipped with STE analysis. The LV 
endocardial and epicardial borders were initially traced at end-diastole, and the 
software automatically tracked the region of interest of the myocardium. Longitudinal 
peak systolic strain (LPSS), was obtained for each segment from which the software 
provided strain curves in all 16 segments. The GLS was calculated as the average of 
the observed segmental values of LPSS from the apical 4-chamber, 3-chamber, and 2-
chamber view (Fig. 1A). For LV circumferential peak systolic strain and radial peak 
systolic, 2D-STE analyses were performed on the LV short-axis midventricular view. 
Global circumferential strain (GCS) and global radial strain (GRS) were calculated as 
the mean of values from LV short-axis views.  
 
LA function analysis 
The biplane Simpson method was used to analyze LA function. LA volume at LV 
end-systole (LAVmax), LA volume at LV end-diastole (LAVmin), and LA volume 
before atrial active contraction at the onset of the P-wave (LAVpreA) were obtained 
from apical 4-chamber and 2-chamber views. All LA volumes were indexed to the 
body surface area [5]. From these volumes, the indexes of LA mechanical function 
were calculated: (1) total atrial emptying fraction: LA total ejection fraction = 
((LAVmax – LAVmin) / LAVmax) × 100; (2) active atrial emptying fraction-an index 
of LA active contraction: LA active ejection fraction = ((LAVpreA – LAVmin) / 
LAVpreA) × 100; (3) passive atrial emptying fraction-an index of LA conduit 
function: LA passive ejection fraction = ((LAVmax – LAVpreA) / LAVmax) × 100; 
(4) atrial expansion index of reservoir function: LA expansion index = (LAVmax – 
LAVmin) / LAVmin × 100 [18].  
For 2D-STE analysis of LA function, 2D grayscale images were obtained in 
apical 4- and 2-chamber views, consistent with software and version for analyzing left 
ventricular strain. To measure PALS (LA reservoir function), the beginning of QRS 
wave of the electrocardiogram was used as a reference point [13]. After selecting the 
cardiac cycle, the LA endocardial border was manually traced, automatically creating 
a region of interest to cover the thickness of LA myocardium from a total of 12 atrial 
segments (Fig. 1B). PALS values were estimated in each LA segment from 2 apical 
views, and the mean of global PALS was calculated. Patients in whom more than two 
segments with poor images could not be analyzed were excluded [2]. 
 
Follow-up and endpoint definition 
At least 6 months after STEMI (18.3 ± 5.0 months), conventional 
echocardiography was performed. LV remodeling assessed by echocardiography was 
defined as an LVEDV increase of > 20% compared with baseline echocardiographic 
data [2]. Cardiovascular medical professionals completed follow-up phone calls in all 
patients each month after discharge from the hospital. Major adverse clinical events 
were a composite of death from any cause, hospitalization for heart failure and 
reinfarction, which were determined by both clinical visits and telephone calls. 
Hospitalization for heart failure occurring because of exacerbation of exertional 
dyspnea, with typical symptoms of pulmonary congestion and initiation of 
intravenous diuretics. Reinfarction was defined as a typical sign of chest pain, 
elevated cardiac enzyme levels, and obvious changes on the electrocardiogram [19]. 
 
Statistical analysis 
Data for continuous variables are presented as the mean ± standard deviation or 
median and interquartile range, and categorical variables are presented as frequencies 
and percentages. Continuous variables are compared using the independent-samples t 
test. Categorical variables were compared by the χ2 test. To examine determinants of 
LV remodeling as a dependent variable, logistic forward regression analysis was 
applied. Univariate analysis was performed to choose the independent variables, and 
those variables with borderline values (p < 0.10) were submitted for multivariate 
analysis. The ability of clinical and echocardiographic parameters to predict adverse 
events were tested in univariate Cox proportional hazards models. To estimate the 
independent prognostic value of the above parameters, multivariate Cox proportional 
hazards analysis was also performed. Receiver operating characteristic (ROC) curve 
analysis were constructed, and areas under curves were measured to determine cutoff 
values with maximum sensitivity and specificity. All statistical tests were two-sided, 




A total of 216 patients with their first acute STEMI treated with pPCI were 
initially evaluated. Seventeen patients were excluded: before echocardiographic 
examination, 2 (0.9%) patients died during hospitalization, and 5 (2.3%) patients were 
not available to undergo echocardiography due to poor cooperation. Another 10 
(4.6%) patients did not have sufficient image quality for tracking of the LV and LA 
walls. No patients were lost to follow-up. Thus, 199 patients were enrolled in the 
present study. Mean age was 57.4 ± 10.7 years, and 150 were males. 
 
Prediction of LV remodeling at 6 months 
At 6-month follow-up, the incidence of adverse LV remodeling was 25%. The 
baseline characteristics and echocardiographic parameters of both the LV remodeling 
group and the non-LV remodeling group are summarized in Table 1. Except for 
diabetes mellitus, the incidence of risk factors associated with cardiovascular disease 
did not differ significantly between the two groups. Anterior wall STEMI appeared in 
106 (52%) patients and was the most common (76%) kind of adverse LV remodeling. 
After immediate pPCI therapy, a comparison of echocardiographic data showed larger 
LVEDV, LVESV and LAVI; lower LVEF, LA total ejection fraction, LA active 
emptying fraction and LA reservoir function and higher WMSI were observed in the 
LV remodeling group. There were significant reductions in both LV GLS and GCS, as 
well as in PALS, regardless of myocardial infarction location.  
Univariate analysis demonstrated the variables to be correlated to the LV 
remodeling, namely diabetes mellitus, CK-MB, LAVI, LA total ejection fraction, LA 
active emptying fraction, LA reservoir function, PALS, WMSI, GLS and GCS. 
Therefore, these parameters were included in a forward stepwise multivariate 
analysis, and diabetes mellitus, GLS and PALS were demonstrated to independently 
predict LV remodeling (Table 2).  
The area under curve (AUC) for LV GLS and PALS were 0.86 and 0.89, 
respectively. However, PALS did not add significant incremental value beyond LV 
GLS (AUC increased from 0.86 to 0.91; p = 0.24) in the prediction of LV adverse 
remodeling. The best cutoff values of LV GLS and PALS for LV remodeling were -
11.3 % (sensitivity: 71.4 %, specificity: 84.0 %) and 28.9 % (sensitivity: 72.7 %, 
specificity: 87.8 %) (Fig 2A-C). 
 
Clinical events during follow-up 
During a mean follow-up of 18.3 ± 5.0 months, 23 patients (11.6 %) reached one 
or more composite endpoints: 3 patients died (1.5 %), 9 patients (4.5 %) had 
reinfarction, and 11 patients (5.5 %) required hospital admission to control heart 
failure symptoms, who were in the event group; the other 176 patients were divided 
into the event-free group. Comparison of clinical and echocardiographic features 
between patients who achieved the composite endpoint and those who did not are 
displayed in Tables 3.  
Diabetes mellitus, LA volume index (LAVI), LA total ejection fraction, LA 
active emptying fraction, LA reservoir function, PALS, LVEF, LV GLS and GCS were 
univariable predictors of adverse events. All these parameters were included in a 
multivariate Cox proportional hazards model, and diabetes mellitus, LV GLS and 
PALS were independently associated with the composite events (Table 4).  
The AUC for LV GLS and PALS were 0.86 and 0.83, respectively. Similarly, 
PALS did not add significant incremental value beyond LV GLS (AUC decreased 
from 0.86 to 0.83; p = 0.69) in the prediction of the composite event. The best cutoff 
values of LV GLS and PALS for LV remodeling were –12.3% (sensitivity: 95.7%, 
specificity: 67.0%) and 28.9% (sensitivity: 88.1%, specificity: 65.2%) (Fig. 3A–C). 
Figure 4A, B showed survival curves by the Kaplan-Meier analysis for patients 
divided by the best value of LV GLS and PALS: patients with LV GLS > –12.3% 
(log-rank χ2= 37.3, p = 0.001) and PALS < 23.8% (log-rank χ2= 47.0, p = 0.001), and 
had composite event rates of 3% and 4%, respectively.  
 
DISCUSSION 
The major results of this study showed the prognostic value of LV GLS and PALS 
measured by 2D-STE in patients with STEMI after pPCI, as follows: (1) reductions in 
PALS and LV GLS are both strongly correlated to LV remodeling and the composite 
event; (2) however, PALS does not add significant incremental prognostic value to LV 
GLS. 
Acute myocardial infarction (AMI) is characterized by regional myocardial 
damage that results in systolic and diastolic dysfunction with a risk of adverse LV 
remodeling. For several decades, previous researchers have focused on the 
pathophysiology and prognosis of LV systolic dysfunction after AMI and have shown 
that LV remodeling mostly occurs in cases of transmural infarction and if at least 20% 
of LV mass is destroyed [3]. Although LVEF and WMSI have traditionally been used 
to evaluate the degree of myocardium injury and even WMSI is considered an 
independent predictor of LV remodeling [20, 21], either of them has limitations for 
risk stratification after AMI [22]. 2D-STE, as a semiautomatic method, is not only 
applied to estimate the motion of the myocyte but also can distinguish the passive and 
active motility of LV segments, suggesting it is a more sensitive measurement of LV 
function [23]. The present results showed that LV GLS not LVEF and WMSI is an 
independent predictor of LV remodeling, and the AUC was 0.86, and the best cutoff 
value was –11.3%, which is similar to the –12.46% reported by Lacalzada et al. [24]. 
This may be because strain can better distinguish between passive and active motion 
of each segment of LV, and hence GLS appears to be more useful than LVEF and 
WMSI in predicting LV remodeling. Hung et al. [10] found that not only GLS but also 
GCS and circumferential strain rate are independent predictors of LV remodeling at 
20 months after adjusting for clinical variables. It seems that circumferential function 
plays an essential role in maintaining LV structure, so circumferential dysfunction 
would lead to LV dilatation. In the current study, GCS was not an independent 
predictor by multivariate analysis. The reason for the contradictory data in predicting 
LV remodeling by GCS may be the different follow-up periods after AMI.  
Park et al. [7] demonstrated that not only GLS showed good predictive value for 
LV remodeling in patients with anterior wall AMI but also predicted death or heart 
failure as composite events, indicating that GLS was also a good predictor of adverse 
clinical events. A previous study confirmed that LV strain and strain rate were 
superior to LVEF and WMSI in risk stratification for long-term outcome, and a GLS 
value > –15.1% was an independent predictor of all-cause mortality [25]. However, 
the VALIANT Echo study, in a sample of 603 patients with LV dysfunction, heart 
failure, or both 5 days after MI, showed that both longitudinal and circumferential 
strain and strain rate are the independent prognostic indicators in patients with high-
risk myocardial infarction [10]. In the present study, it was shown that GLS is an 
independent predictor and the optimal GLS cutoffs for predicting composite events 
is > –12.3%, with a sensitivity and specificity of 95.7% and 67.0%.  
Currently, LA function is assessed by LA volume, mechanical function and strain. 
Previous observation reported that LA volume is significantly related to 
cardiovascular disease and is independently correlated to death or heart failure [26]. 
LA mechanical function consists of the reservoir function, conduit and contractile 
function. LA reservoir function, which reflects LA relaxation, is particularly important 
during acute ischemia [27]. However, assessing changes in LA volume during 
different periods of the cardiac cycle is highly time-consuming; in addition, applying 
a simple geometric model to an asymmetric chamber may affect the estimation of LA 
volume [28]. Recently, by directly evaluating LA myocardial deformation to assess 
LA reservoir function post-AMI, clinically relevant information can be provided. 
PALS, which is evaluated by speckle-tracking derived strain, shows the direct 
evaluation of the atrial myocardium and may better reflect the properties of LA 
[29,30]. Louisa et al. [31] confirmed the value of PALS to predict adverse events in 
patients after AMI treated with PCI, since only 48 of 320 patients (15%) reached the 
composite endpoint. This event rate was higher than the rate herein, where 23 of 199 
patients (11.6%) experienced these events, perhaps due to a significantly shorter 
follow-up time. However, Erolls et al. [16] found that the magnitude of PALS during 
the reservoir phase depends on the GLS and LA size, and measurement of PALS has 
no independent prognostic value. In patients with post-AMI, LA relaxation may be 
damaged by myocyte loss and LV filling pressure may also increase, both of which 
may be present, possibly limiting atrial expansion independently of LV longitudinal 
contraction damage, consequently increasing the risk of LV remodeling and adverse 
events [32, 31]. In the present study, PALS, like LV GLS, was found to be another 
independent predictor of LV remodeling; and a higher PALS value < 23.8%, with a 
sensitivity and specificity of 88.1% and 65.2%, was shown to be an independent 
predictor of a composite event.  
In the current study, the independent prognostic value of PALS and LV GLS in 
patients with STEMI after pPCI was observed. Additionally, PALS did not add 
significant incremental value beyond LV GLS in the prediction of LV remodeling 
(AUC: 0.05, p = 0.24) and clinical events (even a decrease in AUC: 0.03, p = 0.69). 
The highly predictive values of GLS and PALS are further underscored. 
 
Limitations of the study 
A number of limitations of this study should be acknowledged. First, this is a 
single-center experience. In addition, the enrolled population was limited to patients 
with their first STEMI treated with pPCI, with low-risk AMI, and patients who died 
before completing their 6-month echocardiogram were excluded. Therefore, selection 
bias and potential selection bias should be taken into account when interpreting the 
findings. Finally, although the longitudinal, circumferential and radial strain of LV 
was analyzed, the impairment of right ventricular function was not assessed, which 
needs further study.  
 
CONCLUSIONS 
In conclusion, in patients with STEMI in any location treated with pPCI, both LV 
GLS and PALS are both more sensitive to myocardial damage and provide 
independent prognostic value for adverse LV remodeling and clinical events. 
However, the ability of the combination of PALS and GLS to predict LV remodeling 
and clinical outcomes may not be superior to that of a single indicator. 
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Table 1. Baseline characteristics of patients with and without left ventricular remodeling. 
Parameter Non-remodeling 
(n = 150) 
Remodeling 
(n = 49) 
P 
Clinical parameters 
Number 150 (75%) 49 (32%)  
Male 73% 75.5% 0.76 
Age [years] 57.9 ± 10.5 55.9 ± 11.0 0.26 
BMI [kg/m2] 24.5 ± 3.7 24.7 ± 3.9 0.75 
Diabetes  18 (12.0%) 19 (38.8%) 0.001 
Hypertension  65 (43.3%) 18 (36.7%) 0.42 
Hyperlipidemia  53 (35.3%) 18 (36.7%) 0.86 
Smoking  102 (68%) 32 (65.3%) 0.73 
Systolic BP [mmHg] 111.2 ± 16.9 110.5 ± 17.3 0.82 
Diastolic BP [mmHg] 73.1 ± 14.8 69.1 ± 9.6 0.07 
Heart rate [bpm] 74.4 ± 15.3 74.5 ± 7.4 0.95 
QRS width [ms] 97.9 ± 16.4 102.2 ± 21.1 0.14 
S-TO-B [min] 328.0 ± 174.4 383.9 ± 175.6 0.053 
D-TO-B [min] 49.1 ± 19.1 53.2 ± 21.2 0.20 
eGFR [mL/min/1.73 
m2] 
92.1 ± 27.3 99.0 ± 28.8 0.13 
Cr [µmol/L] 71.9 ± 26.3 67.6 ± 11.5 0.19 
Grace (scores) 95.8 ± 26.7 98.7 ± 22.6 0.49 
Crusade (scores) 22.7 ± 13.2 19.9 ± 11.8 0.26 
CKMB [ng/mL] 332.2 ± 143.4 436.2 ± 117.9 0.001 
CKMB peak time after 
onset [h] 
15.5 ± 5.1 19.4 ± 5.2 0.001 
Killip class ≥ II 14 (9.3%) 6 (12%) 0.56 
Anterior wall MI 66 (44.0%) 37 (75.5%) 0.001 
ST max before PCI 
[mm] 
3.8 ± 2.0 4.5 ± 2.4 0.07 
Multivessel coronary 
disease 
42 (28%) 20 (41%) 0.09 
Medication during 
hospitalization 
   
ASA 150 (100%) 49 (100%) 1 
Clopidogrel/Ticagrelor 150 (100%) 49 (100%) 1 
Beta-blockers 113 (75%) 35 (71%) 0.59 
ACEI/ARB 89 (59%) 29 (59%) 0.99 
Statins 135 (90%) 45 (92%) 0.70 
Initial LV function 
LVESV [mL] 86.9 ± 21.6 104.4 ± 28.7 0.001 
LVEDV [mL] 41.3 ± 13.2 56.6 ± 17.6 0.001 
LVEF [%] 52.9 ± 4.5 46.3 ± 3.8 0.001 
WMSI 1.31 ± 0.1 1.37 ± 0.1 0.001 
Deceleration time [ms] 171.3 ± 39.2 159.0 ± 53.4 0.09 
E/A ratio 0.9 ± 0.3 0.9 ± 0.5 0.47 
E/E’ 11.8 ± 3.1 12.5 ± 3.8 0.21 
Moderate or severe MR 6 (4%) 4 (8%) 0.06 
GLS [%] -14.7 ± 2.9 -10.6 ± 2.4 0.001 
GCS [%] -14.5 ± 3.5 -12.7 ± 2.9 0.001 
GRS [%] 39.1 ± 8.6 38.7 ± 7.8 0.75 
LA function 
LAVI [mL/m2] 26.8 ± 5.0 32.8 ± 7.5 0.001 
LA total ejection 54.9 ± 6.0 52.4 ± 5.4 0.01 
fraction [%] 
LA passive emptying 
fraction [%] 
28.3 ± 8.1 28.2 ± 5.6 0.95 
LA active emptying 
fraction [%] 
36.9 ± 6.6 33.7 ± 4.9 0.002 
LA reservoir function 
[%] 
125.7 ± 31.2 112.8 ± 25.7 0.01 
PALS [%] 32.5 ± 5.9 23.0 ± 4.8 0.001 
Follow-up LV function 
LVESV [mL] 88.8 ± 23.1 131.2 ± 35.1 0.001 
LVEDV [mL] 39.1 ± 15.3 74.2 ± 23.4 0.001 
LVEF [%] 56.5 ± 5.8 43.9 ± 3.9 0.001 
Composite endpoint during follow-up 
Total number of 
complications 
9 (6.0%) 14 (29%) 0.001 
Data are expressed as mean ± standard deviation or number (%). ACEI — angiotensin-converting 
enzyme inhibitors; ARB — angiotensin II receptor blocker; ASA — acetylsalicylic acid; BMI — body 
mass index; BP — blood pressure; CK — creatine kinase; Cr — ?????: D-TO-B — door-to-balloon 
time; E/A — mitral inflow peak early velocity/mitral inflow peak late velocity; E/E’ — mitral inflow 
peak early velocity/mitral annular peak early velocity; eGFR — estimated glomerular filtration rate; 
GCS — global circumferential strain; GLS — global longitudinal strain; GRS — global radial strain; 
LA — left atrium; LAVI — left atrium volume index; LV — left ventricular; LVEDV — left 
ventricular end-diastolic volume; LVEF — left ventricular ejection fraction; LVESV — left ventricular 
end-systolic volume; MR — mitral regurgitation; PALS — peak atrial longitudinal strain; ST max — 
maximum ST-segment elevation from a single lead; S-TO-B — symptom-to-balloon time; WMSI — 
wall motion score index 
  
Table 2. Factors predicting adverse left ventricular remodeling after 6-month follow-up in 
univariate and multivariate analysis. 
Parameters OR 95% CI P 
Univariate analysis 
Diabetes 4.64 2.18–9.90 0.001 
CKMB [ng/mL] 1.01 1.0–1.01 0.001 
LA function 
LA max [mL/m2] 1.18 1.11–1.26 0.001 
LA total ejection 
fraction [%] 
0.93 0.88–0.98 0.01 
LA active emptying 
fraction [%] 
0.92 0.87–0.97 0.003 
LA reservoir function 
[%] 
0.98 0.97–0.99 0.01 
PALS [%] 0.71 0.64–0.79 0.001 
LV function 
WMSI 10.70 1.95–58.82 0.006 
GLS [%] 1.81 1.50–2.18 0.001 
GCS [%] 1.21 1.06–1.37 0.004 
Multivariate analysis 
Diabetes 4.93 1.63–14.87 0.005 
PALS [%] 0.77 0.68–0.87 0.003 
GLS [%] 1.36 1.11–1.67 0.001 
CI — confidence interval; CK — creatine kinase; GCS — global circumferential strain; GLS — global 
longitudinal strain; LA — left atrium; LV — left ventricular; OR — odds ratio; PALS — peak atrial 
longitudinal strain; WMSI — wall motion score index 
  
Table 3. Baseline characteristics of patients, event and event-free. 
Parameter Event-free Event P 
Clinical parameters    
Male 72% 87% 0.21 
Age [years] 57.4± 10.5 57.7 ± 11.4 0.90 
BMI [kg/m2] 24.4 ± 3.5 25.3 ± 5.0 0.25 
Hypertension 74 (42.0%) 9 (39.1%) 0.83 
Hyperlipidemia 59 (35.5%) 12 (52.2%) 0.10 
Smoking 116 (65.9%) 18 (78.2%) 0.34 
Systolic BP [mmHg] 110.4 ± 16.3 115.6 ± 21.3 0.17 
Diastolic BP [mmHg] 72.0 ± 13.7 73.1 ± 14.2 0.71 
Heart rate [bpm] 74.6 ± 14.1 73.0 ± 11.3 0.61 
QRS width [ms] 97.4 ± 15.9 110.9 ± 25.2 0.001 
S-TO-B [min] 334.5 ± 176.4 397.2 ± 162.3 0.11 
D-TO-B [min] 48.9 ± 19.5 56.1 ± 19.0 0.10 
eGFR [mL/min/1.73 m2] 93.5 ± 26.2 96.2 ± 38.3 0.66 
Cr [µmol/L] 71.4 ± 24.7 66.6 ± 11.9 0.36 
Grace (scores) 96.6 ± 25.4 95.2 ± 28.9 0.79 
Crusade (scores) 21.8 ± 12.9 22.7 ± 12.4 0.78 
Killip class ≥ II 14 (8.0%) 6 (26.1%) 0.007 
Anterior wall MI 83 (47.2%) 20 (87.0%) 0.001 
CKMB [ng/mL] 347.4 ± 146.5 437.2 ± 98.5 0.005 
CKMB peak time after 
onset [h] 
16.2 ± 5.3 18.4 ± 5.1 0.06 
ST max before PCI 
[mm] 
4.0 ± 2.1 3.7 ± 1.9 0.59 
Multivessel coronary 
disease 
54 (30%) 8 (35%) 0.81 
LA function    
LA max [mL/m2] 27.7 ± 5.8 33.1 ± 7.5 0.001 
LA total ejection fraction 
[%] 
54.7 ± 5.9 50.7 ± 5.3 0.002 
LA passive emptying 
fraction [%] 
28.6 ± 7.6 25.6 ± 7.9 0.07 
LA active emptying 
fraction [%] 
36.4 ± 6.5 33.6 ± 4.4 0.04 
LA reservoir function 
[%] 
124.8 ± 30.6 105.8 ± 22.4 0.003 
Moderate or severe MR 8 (5%) 2 (9%) 0.07 
PALS [%] 31.1 ± 5.9 22.7 ± 5.7 0.001 
Initial LV function    
LVESV [mL] 88.3 ± 21.7 113.5 ± 34.0 0.001 
LVEDV [mL] 42.9 ± 13.4 61.5 ± 17.6 0.001 
LVEF [%] 51.9 ± 5.1 46.6 ± 4.0 0.002 
GLS [%] 
–14.1 ± 3.1 –10.2 ± 1.9 
0.001 
GCS [%] 
–14.2±3.3 –12.6 ± 3.5 
0.03  
Data are expressed as mean ± standard deviation or number (%). 
BMI — body mass index; BP — blood pressure; CK — creatine kinase; Cr — ?????; D-TO-B — 
door-to-balloon time; eGFR — estimated glomerular filtration rate; GCS — global circumferential 
strain; GLS — global longitudinal strain; LA — left atrium; LV — left ventricular; LVEDV — left 
ventricular end-diastolic volume; LVEF — left ventricular ejection fraction; LVESV — left ventricular 
end-systolic volume; MI — myocardial infarction; MR — mitral regurgitation; PALS — peak atrial 
longitudinal strain; PCI — percutaneous coronary intervention; ST max — maximum ST-segment 
elevation from a single lead; S-TO-B — symptom-to-balloon time 
 
 
Table 4. Factors predicting adverse events according to COX proportional hazards regression 
model using univariable and multivariate analysis. 
Parameters HR 95% CI P 
Univariate analysis    
Diabetes 4.96 2.18–11.2 0.001 
CKMB [ng/mL] 1.01 1.00–1.01 0.007 
LA max [mL/m2] 1.14 1.08–1.20 0.001 
LA total ejection fraction 
[%] 
0.90 0.84–0.96 0.01 
LA active emptying 
fraction [%] 
0.93 0.87–0.99 0.04 
LA reservoir function 
[%] 
0.97 0.96–0.99 0.01 
PALS [%] 0.82 0.76–0.88 0.001 
LVEF [%] 0.82 0.76–0.89 0.001 
GLS [%] 1.55 1.31–1.83 0.001 
GCS (%] 1.08 1.01–1.16 0.02 
Multivariate analysis 
PALS [%] 0.88 0.78–0.99 0.04 
GLS [%] 1.30 1.01–1.66 0.03 
Diabetes 4.61 1.50–14.19 0.008 
CI — confidence interval; CK — creatine kinase; GCS — global circumferential strain; GLS — global 
longitudinal strain; HR — hazard ratio; LA — left atrium; LV — left ventricular ejection fraction; 
PALS — peak atrial longitudinal strain 
 
  
Figure 1. A-B. Two-dimensional speckle-tracking of the left ventricle (LV). The resulting 
strain curves for LV are shown with markings corresponding to peak global longitudinal strain 
(GLS) (A); the resulting strain curves for left atrium are shown with markings corresponding 




Figure 2. A–C. Receiver operating-characteristic curve for prediction of left ventricular 
remodeling 6 months after acute myocardial infarction using the independent variable peak 
atrial longitudinal strain (PALS) (A), left ventricular global longitudinal strain (LV GLS) (B) and 






Figure 3. A–C. Receiver operating-characteristic curve for prediction of clinical adverse 
events using the peak atrial longitudinal strain (PALS) (A), left ventricular global longitudinal 





Figure 4. A, B. Survival analysis according to peak atrial longitudinal strain (PALS) and global 
longitudinal strain (GLS) values Kaplan-Meier survival curves for patients according to PALS (the 
optimal cutoff 23.8%) (A) and left ventricular GLS (the optimal cutoff –12.3%) (B). 
 
 
 
